Latest Commercialization News

SPC Global Holdings confirms FY2025 pro forma EBITDA guidance of A$29 million, driven by strong early post-merger performance and strategic initiatives including site consolidation and leadership renewal.

HyTerra Limited has confirmed hydrogen concentrations up to 96.1% in its Sue Duroche 3 well in Kansas, reinforcing the potential of its natural hydrogen exploration program. Elevated helium levels were also detected, with further testing planned to assess commercial viability.

Cardiex Limited has formally lodged its CONNEQT Pulse device with Australia's Therapeutics Goods Administration, marking a critical step toward regulatory approval and market expansion.

Silex Systems reports steady progress on its TRL-6 uranium enrichment demonstration, targeting completion by end-2025, while securing initial US government funding to support commercialisation efforts.

Kingsland Minerals has appointed GR Engineering Services to lead a scoping study for its Leliyn Graphite Project, aiming to unlock the economic potential of one of Australia’s largest graphite resources. The study, supported by new project management expertise and existing off-take agreements, is set to complete by year-end.

Biome Australia is expanding its health portfolio with Activated Therapeutics, a new practitioner-only brand launching four evidence-based natural medicine products in Q4 2025.

Dimerix has received a US$30 million upfront payment from Amicus Therapeutics for exclusive US rights to DMX-200, a promising kidney disease therapy. The deal positions Dimerix for up to US$560 million in further milestones plus royalties, underpinning its global licensing strategy.

Vection Technologies has landed a $1.2 million grant to lead an innovative XR and AI digital twin project aimed at transforming real-time product intelligence in food and beverage manufacturing.

Blue Star Helium has successfully drilled the Jackson 2 well to total depth at its Galactica project in Colorado, confirming strong natural gas flow and advancing the project toward commercial production.

Altech Batteries has launched an operational pilot plant in Germany producing its proprietary Silumina Anodes, promising a 50% increase in lithium-ion battery capacity with improved longevity.

Foresta Group Holdings’ subsidiary partners with New Zealand’s EECA to explore geothermal steam for its flagship biomass facility, aiming to boost sustainability and efficiency.

Bio-Gene Technology Limited is progressing its development of two novel insecticidal compounds, Qcide and Flavocide, targeting major global markets with strong commercial validation and significant US Department of Defense funding.